scholarly journals 191. Examining the Role of Elevated Blood Glucose in the Severity of Arthrofibrosis Using Intra-Articular Gene Delivery of TGF-β1

2009 ◽  
Vol 17 ◽  
pp. S75
2021 ◽  
Author(s):  
Mengna Wu ◽  
Shiyan Nian ◽  
lei feng ◽  
Xuejing Bai ◽  
Dan Ye ◽  
...  

Abstract Background This study was to explore the potential effect of different liver enzymes on elevated blood glucose with the use of a more detailed blood glucose grouping. Methods This cross-sectional study enrolled 144,135 participants who had biochemical examinations from 2014–2018. Participants were classified by sex and different blood glucose levels (< 5.0 mmol/L, 5.0-5.5 mmol/L, 5.6–6.2 mmol/L, 6.3–6.9 mmol/L, and ≥ 7.0 mmol/L). The associations between liver function indicators and occurrence of type 2 diabetes (T2DM) were analyzed through multivariate linear regression and multiple logistic regression. Results There was a significant difference among the biochemical indices between different blood glucose groups in males and females. Liver enzymes such as alanine aminotransferase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), and γ-glutamyl transpeptidase (GGT) were independent risk factors for raised blood glucose, and there were gender differences in the predictive performance of each liver enzyme to elevated blood glucose levels. In men, GGT was the most appropriate to predict progressive elevation of blood glucose or T2DM risk, and ALT and ALP may only be applicable to the prediction of impaired fasting glucose (IFG). By contrast, ALT and ALP were the most appropriate enzymes for the prediction of the risk of elevated blood glucose or T2DM in women, and AST and GGT may only be appropriate for the prediction of IFG. Conclusions Liver enzymes were independent risk factors for elevated blood glucose. There were gender differences in the role of each liver enzyme for elevated blood glucose. GGT was more suitable as a predictor for dynastic elevated blood glucose in men, whereas for women, ALT and ALP were more suitable.


Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 1439-P
Author(s):  
IDA WIUM-ANDERSEN ◽  
RUNGBY JØRGEN ◽  
MARTIN BALSLEV ◽  
JØ RGENSEN ◽  
MERETE OSLER ◽  
...  

2018 ◽  
Vol 18 (2) ◽  
pp. 171-175
Author(s):  
Ashraf A. ◽  
Hassan F. ◽  
Batool S. ◽  
Nadeem M. ◽  
Irshad M. ◽  
...  

The objective of present study was to analyze and compare the nephroprotective effects of petroleum ether extracts of seeds of Nigella sativa and Silybum marianum in Swiss albino mice. Petroleum ether extracts of seeds of Nigella sativa and Silybum marianum were administered (200 mg kg–1) orally for 14 days following one dose of cisplatin injection (16 mg kg–1 i.p.) on 4th day. Cisplatin toxicity was identified in mice by loss of body weight, reduced triglycerides levels, elevated blood glucose, blood urea nitrogen and creatinine levels (P < 0.05). Silybum marianum and Nigella sativa significantly enhanced the body weight (9%) of diabetic rats. Silybum marianum had significantly reduced the elevated blood glucose (–106%), and BUN levels (–9%) as compared to the Nigella sativa administration. Silybum marianum extract also significantly elevated the levels of triglycerides (257%) which were much reduced after the cisplatin injection. Histological study showed that the cisplatin treated group demonstrated the necrosis signs in the glomerulus of Bowman’s capsule, hyalinization and severe cellular damage. The animals administered with extracts showed nearly normal kidney architecture, however, the kidney tissues of Silybum marianum-treated animals showed some improvement with slight signs of cellular damages.


2017 ◽  
Vol 31 (1) ◽  
pp. 101-107 ◽  
Author(s):  
Aimin Yang ◽  
Simin Liu ◽  
Ning Cheng ◽  
Hongquan Pu ◽  
Min Dai ◽  
...  

2008 ◽  
Vol 5 (2) ◽  
pp. 123-134 ◽  
Author(s):  
Hirotaka HAYASHI ◽  
Satoshi OHNO ◽  
Takanari ARAI ◽  
Masuo NAKAI ◽  
Yoshio KATO ◽  
...  

Author(s):  
Anita Nyaboke Ongosi ◽  
Calistus Wilunda ◽  
Patou Masika Musumari ◽  
Teeranee Techasrivichien ◽  
Chia-Wen Wang ◽  
...  

Kenya is experiencing a rising burden of non-communicable diseases (NCDs), yet data to inform effective interventions are limited. We investigated the prevalence of elevated blood pressure, elevated blood glucose and their determinants in a rapidly urbanizing area in Kenya. Data on socio-demographics, dietary and behavioural risk factors, anthropometric measurements, blood pressure, blood glucose, plasma lipids and urinary biomarkers were collected from 221 men and 372 women (25–64 years). Multivariable logistic regression models assessed correlates of elevated blood pressure (EBP) and elevated blood glucose (EBG). Participants’ mean age was 38.0. ± 11.1 years. The prevalence rates of pre-hypertension and hypertension were 49.0% and 31.6% in men and 43.7% and 20.1% in women, respectively, while those of pre-diabetes and diabetes were 8.4% and 8.0% in men and 11.6% and 7.4% in women, respectively. The prevalence of Body Mass Index (BMI) ≥ 25 kg/m2 was higher in women (60.2%) than in men (39.7%). However, both the risk of EBP and EBG were stronger among men than among women. The high prevalence rates of EBP, EBG and overweight/obesity coupled with low physical activity and low fruit and vegetable intake predispose this population to a higher NCD risk. Interventions to mitigate this risk considering the sex differences are urgently required.


1975 ◽  
Vol 41 (6) ◽  
pp. 1717-1721 ◽  
Author(s):  
J. L. Call ◽  
G. E. Mitchell ◽  
C. O. Little

Sign in / Sign up

Export Citation Format

Share Document